Navigation Links
University of Helsinki and ASM International renew research agreement on atomic layer deposition
Date:1/21/2009

Department of Chemistry at the University of Helsinki and ASM Microchemistry Ltd. have renewed their long-term research agreement. ASM Microchemistry Ltd. is a subsidiary of the semiconductor processing tool supplier ASM International N.V. based in the Netherlands. The new agreement is a seamless continuation to the preceding 5-year collaboration project started in 2004 and includes research funding for four PhD students. As part of this collaboration, ASM has located its research and development unit ASM Microchemistry at the campus of the Chemistry Department of the University of Helsinki. The clean room and laboratory were built and opened in 2004 and the office was moved into the campus in early 2006.

The collaboration is about Atomic Layer Deposition (ALD) which is an advanced technology for depositing thin film materials in highly controlled manner for integrated circuits and other applications. Microchemistry and University of Helsinki have been pioneering the ALD technology since 1987 and 1990, respectively. Today ASM is a leading ALD equipment and process supplier to the semiconductor industry, and the University of Helsinki is one of the world's leading academic research institutes in the field of ALD.

As Dr. Marko Tuominen, Managing Director of ASM Microchemistry put it after renewal of the agreement: - The more challenging tasks we give to the University the more successful the scientists are in their work. Also by getting the nearly impossible done greatly strengthens our position in semiconductor industry in the form of intellectual property rights.

Furthermore, Tuominen has found the cooperation and physical location close to University as perfect arrangement for a small research company. He also likes to emphasize that the basic ALD process screening done in the University greatly speeds up the development, since the non-working process options have been ruled out well in advance. This further makes it possible to concentrate more on developing the working processes and transferring these to ASM's business units.

- In the current situation of fragmented research funding, this agreement is exceptional both in terms of length and volume, comment academy professor Markku Leskel and professor Mikko Ritala, who head the ALD research group at the Laboratory of Inorganic Chemistry at the University. - We and our students also greatly appreciate this kind of collaboration with industry which takes us to the area where basic and applied research becomes mixed. The questions we are dealing with in our research are fundamental by their nature, yet their solutions may find rapid use in the future semiconductor devices.


'/>"/>

Contact: Prof. Mikko Ritala
mikko.ritala@helsinki.fi
358-091-915-0193
University of Helsinki
Source:Eurekalert

Related biology technology :

1. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
2. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
3. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
4. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
5. The University of Nottingham in the British Midlands Announces Development of Possible Hepatitis C Vaccine
6. University of Leicester scientists discover technique to help friendly bacteria
7. MichBio Announces Student Career Day at Michigan State University
8. Dr. Thomas Van Dyke Renowned Boston University Professor Joins Imagenetixs Medical Advisory Board
9. University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement
10. Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor
11. McGill University Purchases GenVaults Personal Archive System to Manage Rare Cancer Samples
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... , Feb. 22, 2017  Aratana Therapeutics, Inc. (NASDAQ: ... and commercialization of innovative biopharmaceutical products for companion animals, will ... at 8:30 a.m. ET to discuss financial results from the ... Interested participants and investors may access the ... ...
(Date:2/22/2017)...  PrimeVax Immuno-Oncology, Inc. announced today its CEO, ... Biocom Global Life Science Partnering Conference.  The presentation will ... the Torrey Pines Lodge, in San Diego.  ... who have chosen our company, amongst numerous others, to ... and clinical researchers," said Mr. Chen. "In contrast to ...
(Date:2/22/2017)... Toronto, ON (PRWEB) , ... February 22, 2017 ... ... focused on discovery and development of precision treatments for neurodegenerative diseases, today announced ... trials validate the ProMIS approach.” This is one of a series of commentaries ...
(Date:2/22/2017)... 2017 Dublin - ... Biological Crop Protection (Bio-Pesticide) Market-By Type, By Application, By End User, ... their offering. ... Global Biological Crop Protection Market is forecasted to grow at a ... in biopesticide or biological crop protection market is driven by the ...
Breaking Biology Technology:
(Date:2/2/2017)... TOKYO , Feb. 1, 2017  Central ... innovative and meaningful advances worldwide, The Japan Prize ... Japan Prize, who have pushed the envelope in ... Information and Communication. Three scientists are being recognized ... outstanding achievements that not only contribute to the ...
(Date:1/30/2017)... Jan. 30, 2017   Invitae Corporation (NYSE: ... genetic information companies, today announced that it will report ... provide 2017 guidance on Monday, February 13, 2017, and ... day at 4:45 p.m. Eastern / 1:45 p.m. Pacific. ... will briefly review financial results, guidance, and recent developments ...
(Date:1/25/2017)... NEW YORK , Jan. 25, 2017 /PRNewswire/ ... and Access Management (IAM) lifecycle is comprised of ... infrastructure for the purpose of maintaining digital identities ... enterprise resources and applications. There are significant number ... compliance from time to time by optimizing processes ...
Breaking Biology News(10 mins):